TrialClinical pharmacokinetics2007

Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.

S William Tam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.